These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 1369359)
61. Synthesis of foot-and-mouth disease virus capsid proteins in insect cells using baculovirus expression vectors. Roosien J; Belsham GJ; Ryan MD; King AM; Vlak JM J Gen Virol; 1990 Aug; 71 ( Pt 8)():1703-11. PubMed ID: 2167924 [TBL] [Abstract][Full Text] [Related]
62. Does the VP1 gene of foot-and-mouth disease virus behave as a molecular clock? Elena SF; González-Candelas F; Moya A J Mol Evol; 1992 Sep; 35(3):223-9. PubMed ID: 1325567 [TBL] [Abstract][Full Text] [Related]
63. The position of the heterologous domain can influence the solubility and proteolysis of beta-galactosidase fusion proteins in E. coli. Corchero JL; Viaplana E; Benito A; Villaverde A J Biotechnol; 1996 Jul; 48(3):191-200. PubMed ID: 8861998 [TBL] [Abstract][Full Text] [Related]
64. Expression of the aphthovirus RNA polymerase gene in Escherichia coli and its use together with other bioengineered nonstructural antigens in detection of late persistent infections. Neitzert E; Beck E; de Mello PA; Gomes I; Bergmann IE Virology; 1991 Oct; 184(2):799-804. PubMed ID: 1653502 [TBL] [Abstract][Full Text] [Related]
65. Cloning and expression of enterovirus 71 capsid protein 1 in a probiotic Bifidobacterium pseudocatenulatum. Thinbanmai T; Lulitanond V; Mayo B; Lulitanond A; Panya M Lett Appl Microbiol; 2019 Jan; 68(1):9-16. PubMed ID: 30357884 [TBL] [Abstract][Full Text] [Related]
66. Construction and evaluation of an attenuated vaccine for foot-and-mouth disease: difficulty adapting the leader proteinase-deleted strategy to the serotype O1 virus. Almeida MR; Rieder E; Chinsangaram J; Ward G; Beard C; Grubman MJ; Mason PW Virus Res; 1998 May; 55(1):49-60. PubMed ID: 9712511 [TBL] [Abstract][Full Text] [Related]
67. E. coli expressed proteins as diagnostic reagents for typing of foot-and-mouth disease virus. Suryanarayana VV; Viswanathan S; Ratish G; Bist P; Prabhudas K; Gajendragad MR; Natarajan C Arch Virol; 1999; 144(9):1701-12. PubMed ID: 10542020 [TBL] [Abstract][Full Text] [Related]
68. DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity. Kim SA; Liang CM; Cheng IC; Cheng YC; Chiao MT; Tseng CJ; Lee F; Jong MH; Tao MH; Yang NS; Liang SM J Gene Med; 2006 Sep; 8(9):1182-91. PubMed ID: 16927362 [TBL] [Abstract][Full Text] [Related]
69. Recognition of foot-and-mouth disease virus and its capsid protein VP1 by bovine peripheral T lymphocytes. Garcia-Valcarcel M; Doel T; Collen T; Ryan M; Parkhouse RM J Gen Virol; 1996 Apr; 77 ( Pt 4)():727-35. PubMed ID: 8627261 [TBL] [Abstract][Full Text] [Related]
70. [A new approach to DNA synthesis from synthetic oligonucleotides. Synthesis of DNA coding for the repeated antigenic determinant of foot and mouth disease virus]. Korobko VG; Dobrynin VN; Severtsova IV; Boldyreva EF; Shingarova LN Bioorg Khim; 1987 Jan; 13(1):69-81. PubMed ID: 2436628 [TBL] [Abstract][Full Text] [Related]
71. Expression of poliovirus complementary DNA coding for viral antigenic determinants in Escherichia coli. Kuge S; Chisaka O; Kohara M; Imura N; Matsubara K; Nomoto A J Biochem; 1984 Aug; 96(2):305-12. PubMed ID: 6209264 [TBL] [Abstract][Full Text] [Related]
72. [Primary structure of the DNA copy of the protein VP1 gene of the foot-and-mouth disease virus A22]. Onishchenko AM; Petrov NA; Blinov VM; Vasilenko SK; Sandakhchiev LS Bioorg Khim; 1986 Mar; 12(3):416-9. PubMed ID: 2421736 [TBL] [Abstract][Full Text] [Related]
73. Purification and immunogenicity of fusion VP1 protein of foot and mouth disease virus. Shire SJ; Bock L; Ogez J; Builder S; Kleid D; Moore DM Biochemistry; 1984 Dec; 23(26):6474-80. PubMed ID: 6099140 [TBL] [Abstract][Full Text] [Related]
74. Antigenic specificity of porcine T cell response against foot-and-mouth disease virus structural proteins: identification of T helper epitopes in VP1. Rodríguez A; Sáiz JC; Novella IS; Andreu D; Sobrino F Virology; 1994 Nov; 205(1):24-33. PubMed ID: 7526534 [TBL] [Abstract][Full Text] [Related]
75. Protection conferred by TrpE fusion proteins containing portions of the C-terminal region of capsid protein VP1 of foot-and-mouth disease virus. Giavedoni LD; Kaplan G; Marcovecchio F; Piccone ME; Palma EL J Gen Virol; 1991 Apr; 72 ( Pt 4)():967-71. PubMed ID: 1849980 [TBL] [Abstract][Full Text] [Related]
76. Outer membrane PhoE protein of Escherichia coli as a carrier for foreign antigenic determinants: immunogenicity of epitopes of foot-and-mouth disease virus. Agterberg M; Adriaanse H; Lankhof H; Meloen R; Tommassen J Vaccine; 1990 Feb; 8(1):85-91. PubMed ID: 1690490 [TBL] [Abstract][Full Text] [Related]
77. Expression of an animal virus antigenic site on the surface of a plant virus particle. Usha R; Rohll JB; Spall VE; Shanks M; Maule AJ; Johnson JE; Lomonossoff GP Virology; 1993 Nov; 197(1):366-74. PubMed ID: 7692669 [TBL] [Abstract][Full Text] [Related]